Tags
Blog

'Swedish Neuroscience Institute' posts

Swedish Launches Studies Examining Focused Ultrasound as a Potential Treatment for Parkinson’s disease, Brain Tumors

Swedish Neuroscience Institute leads national ultrasound technology research

 
News Release
 
FOR IMMEDIATE RELEASE                                                                                                          
 

Contact: Clay Holtzman, Swedish, (206) 998-5028, clay.holtzman@swedish.org

SEATTLE — July 30, 2014 — The Swedish Neuroscience Institute (SNI) is expanding its study of focused ultrasound as a novel treatment for brain disorders with the opening of two clinical trials examining the treatment of Parkinson’s disease and brain tumors. The new trials add to the institute’s ongoing study of focused ultrasound for a treatment of essential tremor (ET).
 
“SNI is one of the few locations in the world where focused ultrasound is being studied at this level. These efforts exemplify SNI’s ongoing mission to deliver leading edge treatment for brain and spinal conditions,” said David Newell, M.D., Chief of Neurosciences at SNI. “We are honored to be a pioneer in this field and are eager to produce translational results.”
 
These trials come after SNI launched a study last year examining focused ultrasound’s potential as a treatment for essential tremor, a common neurological disorder resulting in involuntary shaking. The original study was designed to determine viability and safety of ultrasound treatment in improving the quality of life for those affected. Together, these three studies place SNI at the forefront of clinical care providers studying focused ultrasound as a treatment approach.

Seizure Device Evaluated at Swedish Receives FDA Pre-Market Approval

FOR IMMEDIATE RELEASE: Nov. 21, 2013   

Contacts: Clay Holtzman, Swedish, 206-386-2748, clay.holtzman@swedish.org
                   Laura Allen – Swedish Epilepsy Center 206-320-3492

SEATTLE – The U.S. Food & Drug Administration has granted pre-market approval to a California company’s device for the treatment of medically refractory epilepsy that Swedish Neuroscience Institute played a key role in evaluating.

The NeuroPace® RNS® System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs, received FDA premarket approval on Nov. 14, 2013. Created by Mountain View, Calif.-based NeuroPace, the RNS System is a novel, implantable therapeutic device that delivers responsive neurostimulation, an advanced technology designed to continuously monitor electrical activity in the brain, detect abnormal activity and respond by delivering imperceptible levels of electrical stimulation to normalize that activity before an individual experiences seizures.

Swedish physician Ryder Gwinn, M.D., medical director of the Swedish Neurosciences Institute Center for Neuromodulation and Functional Restoration, served as a principal investigator for the device’s feasibility and clinical trials. Swedish was one of 11 centers that evaluated the device’s feasibility and one of 32 centers that conducted the pivotal trial that led to FDA premarket approval. Swedish Neuroscience Institute will initially be the only center in the Pacific Northwest to implant the device.

Amazing Race host and multiple sclerosis advocate Phil Koeghan visits Swedish

 

The Multiple Sclerosis Center at Swedish had a unique visitor last week: Phil Koeghan, host of the Amazing Race (or road warrior for FOX Breakfast Time if you were a mid-90s morning talk show fan).

Phil and his wife, Louise, came by for a tour Friday afternoon and met with some of the Swedish MS Center staff. They were visiting Seattle with their professional bike team to participate in the Multiple Sclerosis Society’s local Bike MS event.

Phil’s team rode Saturday among 135 other teams and individual cyclists, including the Swedish S’Myelin Babes. Swedish’s Bike MS team rallied more than 60 teammates to raise more than $42,300 to support research and advocacy efforts within the MS community.

Free relaxation & stress reduction classes for multiple sclerosis

Stress is something we all experience. At work, home and in relationships—life is a balancing act. For people living with multiple sclerosis (MS), stress can also come from managing major transitions and other emotional changes.

How we respond to stress that determines how it affects our lives. Luckily, we have some control. Learned relaxation techniques can help us manage how we respond to stress and lower its affects before we become overwhelmed ...

Swedish multiple sclerosis neurologists educate about MS with country artist Clay Walker

Neurologists from the Swedish Multiple Sclerosis Center spoke Tuesday evening in Seattle at an educational program featuring country music artist Clay Walker.

Drs. James Bowen and Lily JungHenson gave an update on advancements in multiple sclerosis research to about 200 patients and care partners living with multiple sclerosis (MS). Clay Walker shared his experience living with relapsing-remitting MS and how he manages his symptoms with a busy career.

Results 1-5 of 5
  • 1